Clinical Trial Update: Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study [Phase 4]

View source ↗

Summary

Phase 4 pilot clinical trial evaluating cardiovascular effects of mineralocorticoid receptor activation in primary aldosteronism, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Hypertension

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Primary Aldosteronism, Hypertension | Phase 4 | Status: RECRUITING